Integration and validation of host transcript signatures, including a novel 3-transcript tuberculosis signature, to enable one-step multiclass diagnosis of childhood febrile disease

Our study demonstrates the feasibility of NanoString technology for cross-platform validation of multiple transcriptomic signatures in parallel. This external cohort validated performance of all five signatures, including a novel sparse TB signature. Two exploratory multi-class models showed high potential accuracy across four distinct diagnostic groups.

Authors

Institutions

Publication Details

Journal
Journal of Translational Medicine
Published
2024-08-29
DOI
https://doi.org/10.1186/s12967-024-05241-4
Citations
5
Primary Topic
Tuberculosis Research and Epidemiology
Type
article
Field-Weighted Citation Impact
1.95

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Integration and validation of host transcript signatures, including a novel 3-transcript tuberculosis signature, to enable one-step multiclass diagnosis of childhood febrile disease

Brian Eley, Suzanne T. Anderson, Dominic Habgood-Coote, Andrew Brent et al.
5 citations
Journal of Translational Medicine
Tuberculosis Research and Epidemiology
1.95
article

Integration and validation of host transcript signatures, including a novel 3-transcript tuberculosis signature, to enable one-step multiclass diagnosis of childhood febrile disease

Brian Eley, Suzanne T. Anderson, Dominic Habgood-Coote, Andrew Brent, Myrsini Kaforou, Robert S. Heyderman, Ortensia Vito, Victoria Wright, Samuel Channon‐Wells, Federico Martinón‐Torres, Jethro Herberg, Rachel Galassini, Michael Levin
article en
5 citations

Abstract

Our study demonstrates the feasibility of NanoString technology for cross-platform validation of multiple transcriptomic signatures in parallel. This external cohort validated performance of all five signatures, including a novel sparse TB signature. Two exploratory multi-class models showed high potential accuracy across four distinct diagnostic groups.

Journal of Translational MedicineVol. 22(1)
University of Cape Town (ZA), Universidade de Santiago de Compostela (ES), Instituto de Salud Carlos III (ES), University of Oxford (GB), MRC Clinical Trials Unit at UCL (GB), Complejo Hospitalario Universitario de Santiago (ES), Centro de Investigación Biomédica en Red de Enfermedades Respiratorias (ES), Oxford University Hospitals NHS Trust (GB), University College London (GB), Imperial College London (GB), Royal College of Paediatrics and Child Health (GB)
Queen Mary University of London, Wellcome Trust, National Institute for Health and Care Research, HORIZON EUROPE Framework Programme, NIHR Imperial Biomedical Research Centre
Good health and well-being
Openalex Percentile: Top 14%
Tuberculosis Research and Epidemiology
1.95
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.